Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

55 min ago | The Day

Pfizer to seek approval for psoriasis drug

Pfizer Inc. announced Tuesday that a drug discovered and developed at its Groton laboratories has proven effective enough against plaque psoriasis that it plans to formally request regulatory approval for the remedy next year.

Comment?

Related Topix: Psoriasis, Medicine, Health, Biotech, Healthcare Industry, Pfizer, Food and Drug Administration, Rheumatoid Arthritis, Arthritis

Tue Apr 22, 2014

Reuters

Global Markets-M&a talk lifts European shares, euro dips to two-week low

M&A talk in the pharmaceutical sector lifted European shares on Tuesday, but failed to support the euro, which dipped to a two-week low against the dollar as ECB policymakers renewed efforts to weaken it.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Reuters, Eli Lilly, Financial Markets

The Washington Post

Pfizer and AstraZeneca Ripe for Deal Alone or Together: Real M&A

While the talks between Pfizer, the world's biggest drugmaker, and $87 billion AstraZeneca have fizzled, an analyst at Citigroup Inc. expects Pfizer to approach the company again, or AstraZeneca could opt to merge with another peer such as Amgen Inc. as a defense tactic.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Banking, Financial Services, Citigroup, Amgen, Shire plc, Cancer, Health

The New Zealand Herald

Wall St up as drug deals bolster sentiment

A raft of merger and acquisition activity in the global drug sector helped underpin equities on both sides of the Atlantic, as did better-than-expected earnings from companies including Netflix and Travelers.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Startups, Publishing, Media, IGN Entertainment, News Corporation, Century Media Records, Ottaway Newspapers, Music

Reuters

Novartis, Valeant bids herald new deal-making era for pharma

A series of agreed or proposed drug company deals may herald a new era of acquisitions not seen since last decade as pharmaceutical companies improve their best businesses and exit weaker ones.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Allergan

Sys-Con Media

Active Equities under the Scanner -- Research on JPMorgan Chase, Pfizer, General Motors, and Nokia

The S&P 500 finished the session 0.38% higher at 1,871.89. The gains were broad based as eight out of ten sectors finished on a higher note.

Comment?

Related Topix: Biotech, Wireless, Telecom, Medicine, Nokia, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Automakers, General Motors, Foldrx Pharmaceuticals

BioSpace

Pfizer Inc. Shows Off Top Data For Two Phase 3 Psoriasis Trials

Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis NEW YORK-- Pfizer Inc. announced today top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials Program, OPT Pivotal #1 and OPT Pivotal #2 , evaluating the efficacy and safety ... (more)

Comment?

Related Topix: Psoriasis, Medicine, Health, Biotech, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration

The Globe and Mail

Doctor, please, some more of these: Pharmaceutical shares jump on deals, bid

Doctor, please, some more of these Shares of many of the world's big pharmaceutical companies are surging this morning amid a blockbuster deal, a Botox bid and plain old speculation.

Comment?

Related Topix: AckmanZiff Real Estate Group, Financial Services, Allergan, Biotech, Novartis, GlaxoSmithKline, Medicine, Healthcare Industry

MarketWatch

Europe Markets: Drug stocks drive European markets higher

Drug makers took center stage in European trading Tuesday, with shares of AstraZeneca PLC climbing on news of a potential takeover bid, and GlaxoSmithKline PLC rising as it sells one of its units in a multibillion-dollar deal.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, AstraZeneca Group, Healthcare Industry, GlaxoSmithKline, Stanley

Live Charts

AstraZeneca jumps in US trading on Pfizer takeover speculation

US shares of AstraZeneca surged in New York on Monday on speculation that the company could be at the centre of the largest pharmaceutical takeover in history.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

Mon Apr 21, 2014

Fox News

Wall Street Drifts Higher in Quiet Trading

Wall Street edged up on Monday in light trading as market participants parsed through a hodgepodge of deal news and corporate earnings.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Business News

Wall St. Cheat Sheet

Is Pfizer a Good Portfolio Play?

The company manages its operations through five segments: Primary Care, Specialty Care and Oncology, Established Products and Emerging Markets, Animal Health and Consumer Healthcare, and Nutrition.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Oncology, Nutrition

Freshnews

Kaplan Fox Announces $190 Million Settlement with Pfizer, Inc. and Warner-Lambert Co.

Kaplan Fox & Kilsheimer LLP announces a $190 Million settlement, subject to court approval, with Pfizer, Inc. and Warner-Lambert Co.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Neurontin, Gabapentin (generic), New Jersey

SchaeffersResearch.com

Midday Market Stats: Dow Jones Industrial Average Churns Higher on Pfizer Boost

The Dow Jones Industrial Average has traded in a slim 58-point range today, and at last check, was up 29.8 points, or 0.2%, at 16,438.30, thanks to acquisition-related buzz for Pfizer Inc. .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Netflix, Startups, Restaurant Management, Mcdonalds

TheStreet.com

Watch AstraZeneca, Pfizer, Sarepta and Hasbro Today: StockTwits

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, AstraZeneca Group, Healthcare Industry, Foldrx Pharmaceuticals, Mozilla

Barron's

Morning Movers: AstraZeneca Gains on Acquisition Discussions; Sarepta Surges

Last week's rally is looking more like the real deal and less like a mirage as stock futures tick higher this morning.

Comment?

Related Topix: Biotech, AstraZeneca Group, Medicine, Healthcare Industry

Hispanic Business

Pfizer Invites Public To Listen To Webcast Of April 24 Annual Meeting Of Shareholders

Information on accessing and pre-registering for the live audio webcast will be available at www.pfizer.com beginning today.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

Sun Apr 20, 2014

Benzinga

's Weekend M&A Chatter

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday April 18 through Sunday April 20, 2014.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca, AstraZeneca Group, thePlatform, Cable & Satellite, Comcast

The Washington Post

Pfizer Said to Have Held Now-Dormant Talks to Buy AstraZeneca

Pfizer Inc., the world's biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, according to two people familiar with the matter.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Cancer, Health, Business News

Daily Mail

Viagra drug firm Pfizer mulls A 60bn bid for struggling UK drugs group AstraZeneca

US pharmaceuticals giant Pfizer is mulling a A 60billion bid approach for struggling UK drugs group AstraZeneca, writes Ruth Sunderland.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••